Condition: Chemotherapy, Adjuvant · Lung Adenocarcinoma, Stage I · Treatment · Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.
This description comes directly from the study's public registry record.
Yingran Shen, PhD · 86-18117166317 · elaineshen91@gmail.com
Always discuss trial participation with your own doctor first.
| Thoracic Surgery Department of Shanghai Pulmonary Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03351842